Applying a New Exome Sequencing Method in Medical and Translational Research
/EINPresswire.com/ -- TORONTO, ON--(Marketwired - October 20, 2015) - On Friday, October 23, 2015, a new webinar presented by Roche NimbleGen (hosted by Xtalks), will discuss the use of the SeqCap EZ MedExome Target Enrichment Kit from Roche and other methods at Yale Center for Genome Analysis (YCGA). The keynote speaker will be Dr. Shrikant Mane, Director at Yale Center for Genome Analysis.
Exons make up approximately 2% of the genome, yet contribute to 85% of known Mendelian diseases. With the needs to improve coverage of the medically relevant regions and gain more confidence in variant calling, the research community continues to raise the bar when evaluating the performance of an exome in medical and translational research.
Dr. Mane will also discuss:
- Specific metrics used to evaluate performance of MedExome
- The bioinformatics pipeline used to determine the metrics
- Specific case studies and conditions where MedExome has improved utility
To register or learn more about this complimentary event visit: Applying a New Exome Sequencing Method in Medical and Translational Research
Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global Life Sciences community. Every year thousands of industry practitioners (from pharmaceutical & biotech companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.
To learn more about Xtalks visit http://xtalks.com
For information about hosting a webinar visit http://xtalks.com/sponsorship.ashx
Image Available: http://www.marketwire.com/library/MwGo/2015/10/19/11G068144/Images/ROCHE_logo-sm-438380682449.jpg
Contact:
Dian Razan
Tel: +1 (416) 977-6555 ext 352
Email: drazan@xtalks.com
Roche NimbleGen
Legal Disclaimer:
EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
